
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
        <meta name="author" content="YW Chen">
      
      
        <link rel="canonical" href="https://didiowen.github.io/notes-not-scandal/page/6/">
      
      
      
        <link rel="next" href="../../category/abx/">
      
      
      <link rel="icon" href="../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.5.33">
    
    
      
        <title>Home - Notes Not Scandal</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.3cba04c6.min.css">
      
        
        <link rel="stylesheet" href="../../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../css/timeago.css">
    
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css">
    
    <script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="pink" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#home" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="Notes Not Scandal" class="md-header__button md-logo" aria-label="Notes Not Scandal" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54Z"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Notes Not Scandal
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Home
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: light)" data-md-color-scheme="default" data-md-color-primary="pink" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: dark)" data-md-color-scheme="slate" data-md-color-primary="pink" data-md-color-accent="blue"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="Notes Not Scandal" class="md-nav__button md-logo" aria-label="Notes Not Scandal" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54Z"/></svg>

    </a>
    Notes Not Scandal
  </label>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
    
      
    
  
  
    <li class="md-nav__item">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
        
      
      
        <label class="md-nav__link md-nav__link--active" for="__toc">
          
  
  <span class="md-ellipsis">
    Home
  </span>
  

          <span class="md-nav__icon md-icon"></span>
        </label>
      
      <a href="../.." class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
      
        

  

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#latent-tuberculosis-infection" class="md-nav__link">
    <span class="md-ellipsis">
      Latent tuberculosis infection
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#hiv" class="md-nav__link">
    <span class="md-ellipsis">
      HIV長效針劑
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#americanah" class="md-nav__link">
    <span class="md-ellipsis">
      Americanah
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_2" >
        
          
          <label class="md-nav__link" for="__nav_2" id="__nav_2_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Archive
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_2">
            <span class="md-nav__icon md-icon"></span>
            Archive
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../archive/2024/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2024
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../archive/2023/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2023
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_3" >
        
          
          <label class="md-nav__link" for="__nav_3" id="__nav_3_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Categories
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            Categories
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../category/abx/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    abx
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../category/hiv/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    hiv
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../category/medicine/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    medicine
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../category/reading/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    reading
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../category/taiwanese/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    taiwanese
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../category/tb/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    tb
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../category/travelling/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    travelling
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../category/writing/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    writing
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

  

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#latent-tuberculosis-infection" class="md-nav__link">
    <span class="md-ellipsis">
      Latent tuberculosis infection
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#hiv" class="md-nav__link">
    <span class="md-ellipsis">
      HIV長效針劑
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#americanah" class="md-nav__link">
    <span class="md-ellipsis">
      Americanah
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
  <div class="md-content" data-md-component="content">
    <div class="md-content__inner">
      <header class="md-typeset">
        <h1 id="home">Home<a class="headerlink" href="#home" title="Permanent link">&para;</a></h1>
      </header>
      
        <article class="md-post md-post--excerpt">
  <header class="md-post__header">
    
    <div class="md-post__meta md-meta">
      <ul class="md-meta__list">
        <li class="md-meta__item">
          <time datetime="2024-08-02 00:00:00">August 2, 2024</time></li>
        
          <li class="md-meta__item">
            in
            
              <a href="../../category/medicine/" class="md-meta__link">medicine</a>, 
              <a href="../../category/tb/" class="md-meta__link">tb</a></li>
        
        
          
          <li class="md-meta__item">
            
              3 min read
            
          </li>
        
      </ul>
      
    </div>
  </header>
  <div class="md-post__content md-typeset">
    <h2 id="latent-tuberculosis-infection"><a class="toclink" href="../../medicine/ltbi/">Latent tuberculosis infection</a></h2>
<p>source: Pocket Medicine, 2022; 台灣肺結核診治指引  </p>
<h3 id="whom-to-screen"><a class="toclink" href="../../medicine/ltbi/#whom-to-screen">Whom to screen</a></h3>
<ul>
<li>一個月內新生兒：都要治療  </li>
<li>Open TB：都要檢查  </li>
<li>Smear (-), culture (+)：&lt;13歲、免疫力低下接觸者和同住家人要檢查  </li>
<li>Culture(-)：照CXR即可  </li>
<li>肺外結核、指標個案&lt;5歲：≥5歲接觸者照CXR  </li>
<li>1個月至未滿2歲：TST x 2 (一個月內、暴露滿八週後且與前次間隔八週）  <ul>
<li>判讀標準：已打BCG ≥ 10mm，未打BCG, HIV, 接受anti-lymphokines 或其他免疫抑制治療者 ≥ 5mm為陽性  </li>
<li>治療期滿後TST &lt; 5mm再補打BCG  </li>
</ul>
</li>
<li>2歲以上：暴露滿八週後IGRA  </li>
</ul>
<hr />
<ul>
<li>If screening test ⊕ and no risk factors, confirm prior to treatment; if ⊕ w/ risk factors, proceed to treatment (CID 2017;64:11).  </li>
<li>
<p>Prior to treatment of latent TB, active TB must be ruled out with, at a minimum, ROS for symptoms (cough, fever, night sweats, weight loss), physical exam, and CXR (though may be normal in immunosupp.)  </p>
</li>
<li>
<p>依照證據建議「常規」進行LTBI 的診斷與治療的第一類優先族群包括：愛滋感染者、全年齡層的結核病接觸者、接受抗腫瘤壞死因子治療的病人、洗腎的病人、準備做器官或血液腫瘤移植的病人，以及矽肺症病人。  </p>
</li>
<li>第二類優先族群，支持其進行LTBI 治療的證據比較薄弱，但是診斷及治療LTBI 的益處可能大於傷害。在資源充足的狀況下，若已經推動第一類優先族群的LTBI 診斷與治療，可以將資源投注在此類族群，這類優先族群包括：醫療從業人員、結核病高負擔國家來的移民、矯正機關收容人、遊民以及非法藥物使用者。  </li>
<li>潛伏結核感染陽性若未進行LTBI 治療，排除接觸者檢查即發現為活動性結核病(無法以LTBI 治療來預防)，追蹤每10 萬人年發生率：5-12 歲為840，13-29 歲1,630，30-64 歲880，65-79 歲1,050，80 歲(含)以上可高達1,820  </li>
<li>由於仍然有為數不少的細菌學確診結核病個案，其LTBI 檢驗結果是陰性，故許多指引都指出，當病人出現疑似結核病的症狀，就算LTBI 檢驗結果是陰性，也不能排除病人有結核病的可能  </li>
</ul>
<h3 id="igra"><a class="toclink" href="../../medicine/ltbi/#igra">IGRA</a></h3>
<ul>
<li>Conversion: defined as individuals who initially had a negative test with a subsequent positive result  </li>
<li>Reversion: defined as individuals with an initial positive test with a subsequent negative test  </li>
</ul>
<div class="admonition quote">
<p class="admonition-title">Quote</p>
<p>In a patient population at increased risk for tuberculous disease, such as candidates for organ transplantation, serial testing with interferon-γ release assays before transplant has revealed conversion and reversion rates of reactivity that undermine the ability to determine true-positive rates. [@Roth2016Serialtesting]  </p>
</div>
<h3 id="hiv"><a class="toclink" href="../../medicine/ltbi/#hiv">HIV</a></h3>
<ul>
<li>TST硬結 ≥  5 mm 判定為陽性反應  </li>
<li>在免疫功能不佳，如CD4 淋巴球數低於200 cells/μl 的感染者，在接受抗愛滋病毒藥物治療，並且CD4 淋巴球數增加到大於200 cells/μl 後，建議針對TST 及IGRA 原本呈現陰性反應的病人再做一次檢驗  </li>
<li>IGRA檢驗結果為陽性或不確定 (indeterminate, mitogen-nil &lt;0.5)者，建議加入LTBI 治療  </li>
<li>1HP + Biktarvy  </li>
<li>3HP + DTG-based regimen  </li>
<li>3HR or 4R + DTG BID  </li>
<li>9H  </li>
</ul>
<h3 id="_1"><a class="toclink" href="../../medicine/ltbi/#_1">處方選擇</a></h3>
<table>
<thead>
<tr>
<th><strong>Scenario</strong></th>
<th><strong>Prophylaxis Regimen</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PPD/IGRA ⊕ (regardless of HIV status)</td>
<td>1st line: Rifampin × 4 mo or INH/rifampin daily x 3 mos <em>or</em> INH/rifapentine weekly × 12 wks) (<em>MMWR</em> 2020; 69:1)<br><br><em>Alternative:</em> INH + vitamin B6 × 6-9 mos</td>
</tr>
<tr>
<td>Contact case known or suspected to have MDR TB)</td>
<td>No proven regimen: ? PZA + EMB, ? PZA + FQ</td>
</tr>
</tbody>
</table>
<ul>
<li>
<p>✓ LFTs monthly if receiving INH (risk ↑ w/ age; Chest 2005;128:116): if AST/ALT ↑ 5× ULN or sx (nausea, vomiting, abd pain) → stop TB meds &amp; re-eval  </p>
</li>
<li>
<p>若指標為INH 抗藥，建議選擇4R 處方；RMP 抗藥則選擇9H 處方；多重抗藥性結核病(MDR-TB)個案之接觸者，為預防接觸者感染MDR-TB 發病，建議轉介至抗藥性結核病醫療照護體系(TMTC)，使用fluoroquinolone 類藥物作為LTBI 治療  </p>
</li>
<li>3 類族群不適用3HP：<mark>孕婦</mark>（目前兩大臨床試驗已證實未對寶寶產生影響，但仍需更大量的經驗累積）、INH 或RMP 抗藥指標個案的接觸者、及未滿2歲兒童  <ul>
<li>HP FDC 劑型限於體重50 公斤(含)以上使用固定劑量(不依體重或年齡調整)，每次3 顆，共12 次。  </li>
</ul>
</li>
<li>1HP（每日1 次INH+RPT，共28 次）：僅使用於HIV 感染者及本署專案計畫  </li>
</ul>
<p><img alt="ltbi_flowchart" src="../../assets/images/00746cd3d3ee095042d99b0177e04611_MD5.jpeg" />  </p>
<h3 id="_2"><a class="toclink" href="../../medicine/ltbi/#_2">副作用處理</a></h3>
<ul>
<li>肝炎(ALT &gt;正常值5 倍或臨床有肝炎症狀且ALT&gt;正常值3 倍)造成永久停藥有1%。以年齡層分析，20 歲以下發生率非常低，小於0.3%；超過30 歲發生比例超過2%，主要是60-69 歲年齡層的發生率最高達4%。  </li>
<li>服用3HP 約有41%的病人抱怨有任何一種類流感症狀，皮疹約有11%。  </li>
<li>若治療過程發生定義肝炎的程度，建議先停藥衛教病人，了解病人是否有其他肝炎的風險並予以治療（例如慢性病毒性肝炎），給予支持療法，通常2 週後肝指數會下降1/2，若臨床上沒有不舒服或危險因子，可以2 週甚至1 個月後再追蹤，直到回到正常值上限的2 倍之內即可。  </li>
<li>全身性不適等藥物相關的過敏反應仍然是需要重視的，若符合過敏定義，「不」建議進行同樣處方的re-challenge （可以嘗試轉換其他處方）。  </li>
<li>其餘非過敏反應的不良反應，則視臨床需要給予支持療法，停藥與否視個別病人是否能接受及臨床嚴重度而決定。  </li>
<li>由於3HP/3HR 是由INH 與RPT/RMP 組成，與4R 含有RMP 一樣，極少數可能有骨髓抑制的情況，故當病人有肝病或其他醫療考慮如貧血或血小板相關問題，建議在用藥前檢驗CBC/DC 基礎值，再決定治療中的追蹤方式及頻率。  </li>
<li>使用3HP 最常遇到的不良反應是非肝炎之其他不良反應，例如：疲倦、噁心、頭痛、無力等  </li>
<li>如果發生過敏反應，則建議停藥並視臨床需要給予支持療法。  </li>
<li>若遇到發燒等類流感症狀，最可能的還是3HP 的不良反應，經驗上可先確認病人是否在服藥後幾小時發生，一天內即緩解，那表示藥物相關的機會最大。預先讓病人知道可能的類流感症狀，開立解熱鎮痛劑(例如普拿疼)，讓病人碰到發燒先觀察反應，而不是跑急診。部分病人噁心嘔吐厲害，服藥前可使用止吐劑，來緩解服藥當下的不適。  </li>
<li>各處方間若因副作用或其他因素，得相互轉換；除指標個案對原治療處方抗藥外，轉換後處方按已服用比例，接續服用滿該處方的療程，並儘可能不要短少。  </li>
</ul>
    
  </div>
</article>
      
        <article class="md-post md-post--excerpt">
  <header class="md-post__header">
    
    <div class="md-post__meta md-meta">
      <ul class="md-meta__list">
        <li class="md-meta__item">
          <time datetime="2024-08-01 00:00:00">August 1, 2024</time></li>
        
          <li class="md-meta__item">
            in
            
              <a href="../../category/medicine/" class="md-meta__link">medicine</a>, 
              <a href="../../category/hiv/" class="md-meta__link">hiv</a></li>
        
        
          
          <li class="md-meta__item">
            
              4 min read
            
          </li>
        
      </ul>
      
    </div>
  </header>
  <div class="md-post__content md-typeset">
    <h2 id="hiv"><a class="toclink" href="../../medicine/hiv-long-acting/">HIV長效針劑</a></h2>
<h3 id="cdc"><a class="toclink" href="../../medicine/hiv-long-acting/#cdc">CDC申請條件</a></h3>
<p>（一）18歲以上成人。<br />
（二）近6個月內HIV病毒量&lt;50 copies/mL。<br />
（三）每日口服藥物有困難者，並請敘明理由，如：<br />
1. ﻿﻿吞嚥藥物有困難。<br />
2. ﻿﻿有生理或心理等疾病，不適合每日服藥。<br />
3. ﻿﻿口服藥物產生副作用（如：暈眩、嘔吐等）。<br />
4. 其他<br />
（四）同意配合進行2個月一次的注射。<br />
（五）未感染B型肝炎病毒。<br />
（六）過去無病毒抑制失敗、未對CAB或RPV具有已知或疑似抗藥性。<br />
（七）未使用會與CAB或RPV有明顯藥物交互作用之藥物。<br />
（八）女性未懷孕或未有備孕計畫。<br />
（九）潛伏結核感染（LTBI）檢驗為陰性，或已完成TB/LTBI治療。  </p>
<hr />
<p><img alt="criteria" src="../../assets/images/61f80edbefd2782c97f5ae1d8a3d98be_MD5.jpeg" /><br />
<img alt="ae" src="../../assets/images/32336f2ec353610ec46d1aa41cf6d4cf_MD5.jpeg" /><br />
<img alt="add_criteria" src="../../assets/images/5b8ab8b9f4168d7792ca8a28ebae23a5_MD5.jpeg" />  </p>
<h3 id="general-criteria"><a class="toclink" href="../../medicine/hiv-long-acting/#general-criteria">General criteria</a></h3>
<p>To be eligible for cabotegravir-rilpivirine, patients should:  </p>
<ul>
<li>Be virologically suppressed and adherent to a stable oral regimen for at least <mark style="background: #FFB8EBA6;">6 to 12 months</mark>. The majority of data evaluating cabotegravir-rilpivirine comes from persons with stable viral suppression prior to switching to long-acting injectables, as described above. (See 'Reasons for switching ART' above.)  </li>
<li>Have no documented or suspected resistance mutations that affect activity of cabotegravir or rilpivirine; reasons to suspect such resistance include imperfect adherence or virologic failure while taking a non-nucleoside reverse transcriptase inhibitor (NNRTI) or an integrase strand transfer inhibitor (INSTI) in the past. In some studies, baseline rilpivirine proviral resistance mutations were a significant predictor of virologic failure with cabotegravir-rilpivirine.  </li>
<li>Ideally, patients should have no <mark style="background: #FFF3A3A6;">history of virologic failure (even with NNRTI/INSTI regimens)</mark>. However, certain acquired resistance mutations may be acceptable if there are no other good treatment options. Trials generally excluded individuals with any history of virologic failure; the only resistance mutation typically permitted for enrollment in the trials was a <mark style="background: #FFB8EBA6;">K103N mutation</mark> (the NNRTI mutation associated with resistance to efavirenz, which may be acquired at time of HIV acquisition).  </li>
<li>Be able and willing to adhere to clinic visits for IM injections. The injections must be administered by a health care professional; they are not approved for at-home use or self-administration.  </li>
<li>Two-drug regimens, including long-acting injectable therapy, should generally be avoided in patients with <mark style="background: #FFF3A3A6;">chronic hepatitis B virus (HBV) infection</mark>, as such patients should receive a tenofovir-containing ART regimen whenever possible. (See "Treatment of chronic hepatitis B in patients with HIV".)  </li>
</ul>
<h3 id="additional-considerations"><a class="toclink" href="../../medicine/hiv-long-acting/#additional-considerations">Additional considerations</a></h3>
<p>When determining if cabotegravir-rilpivirine is a suitable regimen for a patient, we also assess the following factors:  </p>
<h4 id="drug-drug-interactions"><a class="toclink" href="../../medicine/hiv-long-acting/#drug-drug-interactions">Drug-drug interactions</a></h4>
<p>There are a few drug-drug interactions that are contraindications to parenteral cabotegravir-rilpivirine. These include <mark style="background: #FFF3A3A6;">rifamycins</mark> (rifampin, rifabutin, rifapentine), certain anticonvulsants (carbamazepine, oxcarbazepine, phenobarbital, phenytoin), St. John's wort, and dexamethasone (if more than a single dose).  </p>
<p>IM cabotegravir-rilpivirine should also be used with caution with drugs known to cause <mark style="background: #FFF3A3A6;">prolonged QT or Torsade de Pointes</mark> or in patients with a history of these conditions.  </p>
<p>Cabotegravir may lead to <mark style="background: #FFF3A3A6;">decreased levels of methadone</mark>. Although use of methadone is not a contraindication to IM cabotegravir-rilpivirine, clinical monitoring is recommended and patients may need adjustment of their methadone dose if withdrawal symptoms occur.  </p>
<p>In persons with mpox, initiation of long-acting cabotegravir-rilpivirine should be avoided during <mark style="background: #FFF3A3A6;">tecovirimat</mark> therapy and for two weeks after the conclusion of tecovirimat.  </p>
<h4 id="buttock-implantsfillers"><a class="toclink" href="../../medicine/hiv-long-acting/#buttock-implantsfillers">Buttock implants/fillers</a></h4>
<p>For patients with buttock implants or fillers, the injections may not be an option. The medications are approved only for administration in the gluteal region. Data for injections in the vastus lateralis are anticipated in the future.  </p>
<h4 id="hiv-subtype"><a class="toclink" href="../../medicine/hiv-long-acting/#hiv-subtype">HIV subtype</a></h4>
<p>In some studies, there was a higher likelihood of virologic failure in patients with HIV subtype A1 or A6 virus (which most often occurs in Eastern Europe and Central Asia and which has been associated with certain integrase gene polymorphisms). In general, this finding doesn't impact our decision to initiate cabotegravir-rilpivirine since virologic failures were rare in the trials (13 out of 1039 participants) and viral subtypes are usually not known. However, we would discuss the possible increased risk of virologic failure if it is known that a patient has subtype A virus or comes from a region with predominance of subtype A virus (see "Global epidemiology of HIV infection"). Viral subtype may not be known though sometimes is reported as part of a genotype resistance assay so a clinician may be able to confirm this information by reviewing past resistance assay results.  </p>
<h4 id="body-mass-index"><a class="toclink" href="../../medicine/hiv-long-acting/#body-mass-index">Body mass index</a></h4>
<p>In one study, body mass index (BMI) above 30 kg/m2 was associated with an increased risk of virologic failure. However, the association of high BMI and virologic failure has not been reproduced. With elevated BMI, we do generally opt for a longer needle for injections and pay extra attention to site of administration. (See 'Dosing and administration' below.)</p>
    
  </div>
</article>
      
        <article class="md-post md-post--excerpt">
  <header class="md-post__header">
    
    <div class="md-post__meta md-meta">
      <ul class="md-meta__list">
        <li class="md-meta__item">
          <time datetime="2024-07-17 00:00:00">July 17, 2024</time></li>
        
          <li class="md-meta__item">
            in
            
              <a href="../../category/reading/" class="md-meta__link">reading</a></li>
        
        
          
          <li class="md-meta__item">
            
              2 min read
            
          </li>
        
      </ul>
      
    </div>
  </header>
  <div class="md-post__content md-typeset">
    <h2 id="americanah"><a class="toclink" href="../../reading/americanah/">Americanah</a></h2>
<p>author:: Chimamanda Ngozi Adichie<br />
year:: 2013  </p>
<h3 id="thoughts"><a class="toclink" href="../../reading/americanah/#thoughts">Thoughts</a></h3>
<ul>
<li>一開始聽朗讀者一下子用標準英文、一下子用奈及利亞腔英文切來切去有點不習慣，不過聽一陣子也就習慣了。  </li>
<li>奈及利亞的官方語言是英文，書中的人物從小就會說英文，但女主角Ifemelu一開始到美國時卻會因為她的奈及利亞腔在日常生活和求職時被認為她不諳英語，因此她努力學習美國腔多年，但奈及利亞腔偶爾還是會在緊張時流露。某天她突然決定重拾奈及利亞腔，不再刻意維持美國口音。是啊，為什麼我們一直為了口音自卑呢？  </li>
<li>Ifemelu的姑姑是醫生，為了追尋美國夢移居美國之後卻不停在抱怨生活的一切，似乎沒有變得更快樂，她的兒子更是在青少年時期因為憂鬱症自殺未遂。Ifemelu剛到美國住在姑姑家當侄子保母時曾被姑姑訓斥不要跟侄子講母語Igbo，但當侄子長大後來到奈及利亞找Ifemelu待了幾週，卻說”I wish I knew how to speak Igbo.” 最近在讀的另一本書<a href="../../../Speak Not">Speak Not</a>有提到，在加拿大和澳洲的原住民部落做的研究中發現，母語還未消失的部落其失業率、自殺率、酗酒率都比較低，教育程度也較只能使用英語的部落更高。  </li>
</ul>
<hr />
<h3 id="quotes"><a class="toclink" href="../../reading/americanah/#quotes">Quotes</a></h3>
<div class="admonition quote">
<p class="admonition-title">Chapter 20</p>
<p>”You see, in American pop culture, beautiful dark women are invisible. The other group just as invisible is Asian men, but at least they get to be super smart.”  </p>
</div>
<blockquote>
<p>種種部落意識中，最讓美國人不自在的莫過於種族意識。如果你跟一個美國人聊天，你想要討論某件攸關種族、你覺得頗有意思的事情、那位美國仁兄卻說：「喔，你說這事攸關種族，未免過於單純。種族議題真的非常複雜。」其實他只是想要請你住嘴。因為啊，種族議題當然複雜。昔日許多廢奴主義者都主張解放黑奴，但不希望黑人住在附近。現今許多民眾都不介意有個黑人保母或是黑人轎車司機，但可非常介意有個黑人上司。聲稱「種族議題非常複雜」才是過於單純。但你還是住嘴吧，尤其你若有求於那位美國仁兄。  </p>
<p>多元化對不同的人具有不同的意涵。當白人說一個社區相當多元化，他們的意思是說該社區的居民有百分之九是黑人。(若該社區的黑人居民一達百分之十，白人會立刻遷出。) 如果黑人說一個社區相當多元化，他們的意思是該社區有百分之四十的黑人居民。  </p>
<p>有時當美國人提及「文化」，他們的意思是「種族」。當他們說一部電影是「主流影片」，他們的意思是「這部電影是白人拍的」或是「這部電影白人會喜歡」。當他們說某個地方很「都會」，他們的意思是那裡是黑人區、很貧窮、說不定有點危險、可能很刺激。所謂「帶有種族歧視色彩」，其實只是大家不情願直說「種族歧視」。  </p>
</blockquote>
<h3 id="related"><a class="toclink" href="../../reading/americanah/#related">Related</a></h3>
<div class="admonition note">
<p class="admonition-title"><a href="https://www.facebook.com/chingchun.shih/posts/pfbid02pQTHaVUFCTfEiJqoDEcJUcZwLWANCs1Gv1u2RYSDAFMKtmxj6pZFT67yowAM63DPl">譯者施清真</a>：</p>
<p>《美國佬》是導演葛蕾塔 ‧ 潔薇最喜歡的小說之一。潔薇說，阿迪契架構出的浪漫跟珍 ‧ 奧斯丁的小說一樣迷人，只不過是把場景設定在奈及利亞和美國。她還說，她深深愛上小說的主角歐賓澤和伊菲美廬，自從小時候頭一次閱讀小說，她已經許久未曾興起同樣的感覺。  </p>
</div>
<h4 id="_1"><a class="toclink" href="../../reading/americanah/#_1"><a href="https://www.facebook.com/chingchun.shih/posts/pfbid02rDBmgrG7W4KjaBUkZ1ZRuUxsBGmVKw5Hh4JpVSBENHwsPJVAQwzatMxPcVDJC7Sol">譯者施清真推薦文</a></a></h4>
<p>2003 年，阿迪契以《紫木槿》（Purple Hibiscus）躍登文壇，至今發表四部小說，《美國佬》是篇幅最長、最具企圖心的一部，《美國佬》獲獎無數，在此不再贅述，我只想從讀者與譯者的觀點，說一說這本小說。  </p>
<p>《美國佬》的主角是一對年輕戀人伊菲美廬和歐賓澤，兩人在中學時代墜入情網，而後各分東西，多年之後重新聚首，怎知人事已非，感情面臨重大考驗。他們讓我想起《正常人》的年輕情侶梅黎安與康納，但伊菲美廬和歐賓澤不僅承受內心的糾葛，更承負著大時代的悲喜，阿迪契藉由他們之口，述說英美兩國的種族議題，換言之，《美國佬》不僅是個愛情故事，而是具有更深一層的意涵。  </p>
<p>《美國佬》聚焦於種族，而阿迪契從「非美國黑人」的視角解析種族，提供另一種思索觀點。伊菲美廬和歐賓澤在奈及利亞從未因為膚色受到歧視，身處英美之時，他們卻被冠上「黑人」的標籤，承受不一樣的眼光，由此衍生出獨特的文化觀察，比方說少數族裔如何看待少數族裔，《美國佬》一書中，歐賓澤一個大學好友落籍英國、娶了一個英國太太，自此跟奈及利亞劃清界線，非但看不起奈及利亞人，甚至生怕被視為奈及利亞人。少數族裔客居異鄉，為了生存，為了上進，不得不向主流族裔靠攏，甚至輕慢自己的族裔，想來氣怒，其實相當悲哀。  </p>
<p>阿迪契能寫，也敢寫，《美國佬》嘲諷所謂的「美國黑人菁英」，筆鋒辛辣尖銳，令人叫絕。比方說小珊，小珊是伊菲美廬第二任男友布萊恩的姐姐，阿迪契筆下的小珊聰穎嬌美、迷倒眾生，卻也極度自戀、囂張跋扈，小珊身旁的一干友人也是不時掉書袋，生活在象牙塔中，阿迪契以敏銳的觀察和生花妙筆，寫活了這群自詡為文化菁英、實則與現實脫節的黑人知識份子。  </p>
<p>阿迪契對她的同胞亦是毫不留情。她筆下的那些「海歸派」奈及利亞菁英，頂著英美名校的光環回國求職，但奈及利亞的一切都讓他們看不慣，經常聚在一起吐苦水，這群人絕對不會讓你忘記他們出身名校，開口閉口抱怨奈及利亞沒有素食餐廳，言談之中總是夾帶英文，譯寫之時，我想到自己碰過的一些「歸國學人」，不禁會心一笑。  </p>
<p>好書永遠太多，時間永遠太少。你若問我，在眾多好書之中，《美國佬》為何值得一讀？且讓我以作家張亦絢的導讀作為回答：「純就小說而言，《美國佬》的流暢好讀或會讓人誤以為缺乏深度，但其實是在『深入淺出』的『淺出』上，做足了工夫。作者很細緻地沒有讓任何冗長的歷史陳述，打斷或窒息讀者－但讀者讀完，絕對會對相關歷史，大感興趣 - 這就是一個小說家對文學與歷史所能有的，最佳雙重貢獻。」這話切中我心，也對《美國佬》下了最佳註腳。  </p>
<ul>
<li><a href="https://www.facebook.com/chingchun.shih/posts/pfbid031zRWYGiRcfMJPXeW9zDPzGeMHBP465L74eBXRpHYYfG2S9FGYeCX9qcwHPdmFuy4l">施清真第二篇介紹</a>  </li>
<li><a href="../../../《美國佬》導讀：一個小說家對文學與歷史所能有的，最佳雙重貢獻">《美國佬》導讀：一個小說家對文學與歷史所能有的，最佳雙重貢獻</a>  </li>
<li><a href="../../../繞頸之物到壓頂之重：蔣亞妮讀阿迪契的《美國佬》">繞頸之物到壓頂之重：蔣亞妮讀阿迪契的《美國佬》</a></li>
</ul>
    
  </div>
</article>
      
      
        
          



<nav class="md-pagination">
  <a class="md-pagination__link" href="../..">1</a> <span class="md-pagination__dots">..</span> <a class="md-pagination__link" href="../4/">4</a> <a class="md-pagination__link" href="../5/">5</a> <span class="md-pagination__current">6</span> <a class="md-pagination__link" href="../7/">7</a> <a class="md-pagination__link" href="../8/">8</a> <a class="md-pagination__link" href="../9/">9</a>
</nav>
        
      
    </div>
  </div>

          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
      </main>
      
        <footer class="md-footer">
  
    
      
      <nav class="md-footer__inner md-grid" aria-label="Footer" >
        
        
          
          <a href="../../category/abx/" class="md-footer__link md-footer__link--next" aria-label="Next: abx">
            <div class="md-footer__title">
              <span class="md-footer__direction">
                Next
              </span>
              <div class="md-ellipsis">
                abx
              </div>
            </div>
            <div class="md-footer__button md-icon">
              
              <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M4 11v2h12l-5.5 5.5 1.42 1.42L19.84 12l-7.92-7.92L10.5 5.5 16 11H4Z"/></svg>
            </div>
          </a>
        
      </nav>
    
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "../..", "features": ["navigation.path", "navigation.footer"], "search": "../../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    
      <script src="../../assets/javascripts/bundle.af256bd8.min.js"></script>
      
        <script src="../../js/timeago.min.js"></script>
      
        <script src="../../js/timeago_mkdocs_material.js"></script>
      
        <script src="../../javascripts/mathjax.js"></script>
      
        <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
      
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
      
        <script src="https://cdn.jsdelivr.net/gh/ObsidianPublisher/assets@main/dist/javascript.js"></script>
      
    
  </body>
</html>